Wealth Alliance Horizon Therapeutics Public LTD CO Transaction History

Wealth Alliance

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$107.32 - $113.5 $214,640 - $227,000	2,000 New	2,000 $218,000
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $34,468 - $49,531	-585 Reduced 12.0%	4,288 $266,000
Q2 2022 Oct 11, 2022	BUY	$79.4 - $116.36 $158,800 - $232,720	2,000 Added 69.61%	4,873 $389,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $130,692 - $191,528	-1,646 Reduced 36.42%	2,873 $229,000
Q1 2022 May 10, 2022	SELL	$86.42 - $109.81 $9,506 - $12,079	-110 Reduced 2.38%	4,519 $475,000
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $8,180 - $9,952	-83 Reduced 1.76%	4,629 $499,000
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $81,432 - $97,787	-886 Reduced 15.83%	4,712 $516,000
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $72,527 - $80,668	841 Added 17.68%	5,598 $524,000
Q1 2021 May 18, 2021	SELL	$71.83 - $95.48 $193,869 - $257,700	-2,699 Reduced 36.2%	4,757 $438,000
Q4 2020 Feb 11, 2021	SELL	$67.0 - $84.39 $938 - $1,181	-14 Reduced 0.19%	7,456 $545,000
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $11,046 - $15,986	200 Added 2.75%	7,470 $580,000
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $219,554 - $414,244	7,270 New	7,270 $404,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.